Sickle cell disease (SCD) is the most common inherited blood cell disorder in the U.S., according to the American Society of Hematology. Bone marrow transplant (BMT), or allogeneic hematopoietic stem cell transplant, is considered the only potentially curative therapy for SCD.
Read More →Cancer Desk India
Search Cancer Hospital
Disclaimer!
This website does not endorse or recommend any commercial products, process, services or centers. Though all efforts have been made to ensure the accuracy of the content on this website, cancerdeskindia.com accepts no responsibility in relation to the accuracy, completeness, usefulness or otherwise, of the contents. Users are advised to verify/check any information, and to obtain any appropriate professional advice before acting on the information provided on this website.
This website does not endorse or recommend any commercial products, process, services or centers. Though all efforts have been made to ensure the accuracy of the content on this website, cancerdeskindia.com accepts no responsibility in relation to the accuracy, completeness, usefulness or otherwise, of the contents. Users are advised to verify/check any information, and to obtain any appropriate professional advice before acting on the information provided on this website.
Latest News
Latest News
Multidisciplinary sickle cell program includes curative bone marrow transplant
Sickle cell disease (SCD) is the most common inherited blood cell disorder in the U.S., according to the American Society of Hematology. Bone marrow transplant (BMT), or allogeneic hematopoietic stem cell transplant, is considered the only potentially curative therapy for SCD.
Read More →